PI-RADS Prostate Imaging–Reporting and Data System: 2015, Version 2

Artículos que citan PI-RADS Prostate Imaging–Reporting and Data System: 2015, Version 2

Título / Autor	Año
MRI-targeted or standard biopsy for prostate-cancer diagnosis V Kasivisvanathan, AS Rannikko, M Borghi, V Panebianco, LA Mynderse, ... New England Journal of Medicine 378 (19), 1767-1777	2018
Prostate magnetic resonance imaging and magnetic resonance imaging targeted biopsy in patients with a prior negative biopsy: a consensus statement by AUA and SAR AB Rosenkrantz, S Verma, P Choyke, SC Eberhardt, SE Eggener, ... The Journal of urology 196 (6), 1613-1618	2016
The diagnosis and treatment of prostate cancer: a review MS Litwin, HJ Tan Jama 317 (24), 2532-2542	2017
What is the negative predictive value of multiparametric magnetic resonance imaging in excluding prostate cancer at biopsy? A systematic review and meta-analysis from the European Association of Urology Prostate Cancer Guidelines Panel PC Moldovan, T Van den Broeck, R Sylvester, L Marconi, J Bellmunt, ... European urology 72 (2), 250-266	2017
68 Ga-PSMA ligand PET/CT in patients with prostate cancer: How we review and report I Rauscher, T Maurer, WP Fendler, WH Sommer, M Schwaiger, M Eiber Cancer Imaging 16 (1), 14	2016
Diagnostic performance of prostate imaging reporting and data system version 2 for detection of prostate cancer: a systematic review and diagnostic meta-analysis S Woo, CH Suh, SY Kim, JY Cho, SH Kim European urology 72 (2), 177-188	2017
Diagnostic pathway with multiparametric magnetic resonance imaging versus standard pathway: results from a randomized prospective study in biopsy-naive patients with suspected prostate cancer F Porpiglia, M Manfredi, F Mele, M Cossu, E Bollito, A Veltri, S Cirillo, ... European urology 72 (2), 282-288	2017
Accuracy and agreement of PIRADSv2 for prostate cancer mpMRI: a multireader study MD Greer, AM Brown, JH Shih, RM Summers, J Marko, YM Law, ... Journal of Magnetic Resonance Imaging 45 (2), 579-585	2017
Reporting magnetic resonance imaging in men on active surveillance for prostate cancer: the PRECISE recommendations—a report of a European School of Oncology Task Force CM Moore, F Giganti, P Albertsen, C Allen, C Bangma, A Briganti, ... European urology 71 (4), 648-655	2017
Proposed adjustments to PI-RADS version 2 decision rules: impact on prostate cancer detection AB Rosenkrantz, JS Babb, SS Taneja, JM Ream Radiology 283 (1), 119-129	2016
Optimising the diagnosis of prostate cancer in the era of multiparametric magnetic resonance imaging: a cost-effectiveness analysis based on the Prostate MR Imaging Study (PROMIS) R Faria, MO Soares, E Spackman, HU Ahmed, LC Brown, R Kaplan, ... European urology 73 (1), 23-30	2018
Magnetic resonance imaging underestimation of prostate cancer geometry: use of patient specific molds to correlate images with whole mount pathology A Priester, S Natarajan, P Khoshnoodi, DJ Margolis, SS Raman, ... The Journal of urology 197 (2), 320-326	2017
Abbreviated biparametric prostate MR imaging in men with elevated prostate-specific antigen CK Kuhl, R Bruhn, N Krämer, S Nebelung, A Heidenreich, S Schrading Radiology 285 (2), 493-505	2017
The role of multiparametric magnetic resonance imaging/ultrasound fusion biopsy in active surveillance TM Ma, JJ Tosoian, EM Schaeffer, P Landis, S Wolf, KJ Macura, JI Epstein, ... European urology 71 (2), 174-180	2017
Multicentre evaluation of targeted and systematic biopsies using magnetic resonance and ultrasound image‐fusion guided transperineal prostate biopsy in patients with a previous negative biopsy NL Hansen, C Kesch, T Barrett, B Koo, JP Radtke, D Bonekamp, ... BJU international 120 (5), 631-638	2017
The efficiency of multiparametric magnetic resonance imaging (mpMRI) using PI-RADS Version 2 in the diagnosis of clinically significant prostate cancer C Zhao, G Gao, D Fang, F Li, X Yang, H Wang, Q He, X Wang Clinical imaging 40 (5), 885-888	2016
Results of targeted biopsy in men with magnetic resonance imaging lesions classified equivocal, likely or highly likely to be clinically significant prostate cancer W Venderink, A van Luijtelaar, JGR Bomers, M van der Leest, ... European urology 73 (3), 353-360	2018
T2-weighted MRI-derived textural features reflect prostate cancer aggressiveness: preliminary results G Nketiah, M Elschot, E Kim, JR Teruel, TW Scheenen, TF Bathen, ... European radiology 27 (7), 3050-3059	2017
Comparison of 68Ga-HBED-CC PSMA-PET/CT and multiparametric MRI for gross tumour volume detection in patients with primary prostate cancer based on slice by slice comparison with histopathology C Zamboglou, V Drendel, CA Jilg, HC Rischke, TI Beck, ... Theranostics 7 (1), 228	2017
Clinically localized prostate cancer: AUA/ASTRO/SUO guideline MG Sanda, RC Chen, T Crispino, S Freedland, MD Nelson, J Reston, ... Risk 6, 27	2017

1 - 20

Las fechas y los recuentos de citas son estimados y se determinan de forma automática mediante un programa informático.